Fact based stock research
C.R. Bard (NYSE:BCR)


C.R. Bard stock research in summary

crbard.com


C.R. Bard shares have a HOLD rating. They show above average growth and are safely financed, but are bad value. We recommend holding C.R. Bard shares.


Latest Obermatt Ranks


Country USA
Industry Health Care Equipment
Index
Size class Medium

December 7, 2017. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()







 

Research History: C.R. Bard

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
13
32
14
15
STOCK GROWTH RANKS
48
29
83
89
STOCK SAFETY RANKS
60
68
62
53
COMBINED STOCK RANKS
28
38
37
50

Last update of Combined Rank: 7-Dec-2017. Stock research history is based on the Obermatt Method. The higher the rank, the better is C.R. Bard in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 7-Dec-2017. Stock analysis on value ratios: The higher the rank, the lower the value ratio of C.R. Bard; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
37
41
46
50
PROFIT GROWTH
44
27
89
83
STOCK RETURNS
62
59
87
90
CONSOLIDATED RANK: GROWTH
48
29
83
89

Financial reporting date of Growth Rank: 30-Sep-2017. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of C.R. Bard.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
28
32
70
77
REFINANCING
17
13
LIQUIDITY
86
91
74
74
CONSOLIDATED RANK: SAFETY
60
68
62
53

Financial reporting date of Safety Rank: 30-Sep-2017. Stock analysis on safety metrics: The higher the rank, the lower the leverage of C.R. Bard and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for C.R. Bard from December 7, 2017.